CT Calcium Scoring: What It Is and What Your Score Means

A CT calcium score is a number that reflects how much calcified plaque has built up in your coronary arteries, measured by a quick, low-dose CT scan of the heart. The result, expressed as an Agatston score, ranges from zero (no detectable calcium) to well over a thousand, and it serves as one of the strongest independent predictors of future heart attack and cardiovascular death. The scan takes about ten minutes and does not require contrast dye or an IV, yet the information it provides has reshaped how doctors decide who needs preventive medication and who can safely skip it.

How the Scan Works

A coronary artery calcium (CAC) scan uses a CT scanner synchronized to your heartbeat through ECG gating, which times each image to the brief pause between beats so the pictures come out sharp despite the heart’s constant motion. You lie on a table, electrodes are placed on your chest, and the scanner takes a series of thin cross-sectional images of your heart in a single breath-hold lasting roughly ten seconds. No contrast dye is injected, and no special preparation is needed beyond avoiding caffeine for a few hours beforehand.

The images are then analyzed for bright white spots in the coronary arteries, which represent calcium deposits embedded in plaque. Each spot above a certain density threshold is measured for area and density, and those measurements are combined into a single number called the Agatston score. The method was developed in the late 1980s after electron beam CT made it possible to image the beating heart fast enough to freeze its motion, and it has remained the standard scoring system ever since.

What the Score Ranges Mean

The Agatston score is typically grouped into broad categories that correspond to increasing levels of plaque burden and cardiovascular risk:

• 0: No detectable calcified plaque. Very low short-term risk of a coronary event.
• 1 to 100: Mild plaque. Some buildup is present, but event rates remain relatively low.
• 101 to 400: Moderate plaque. Risk increases meaningfully, and preventive treatment is usually discussed.
• Above 400: Extensive plaque. High risk; aggressive risk-factor management is typically recommended.
• Above 1,000: Very high plaque burden. Guidelines specifically flag this threshold for special attention.

A study following outpatients found that the three-year rate of major adverse cardiac events rose sharply across these strata: roughly 2% for a score of zero, about 13% for scores of 1 to 100, around 16% for 101 to 400, and about 34% for scores above 400.¹ These rates come from a symptomatic population referred for testing, so the absolute numbers are higher than you would see in asymptomatic screening, but the gradient illustrates why the score matters: more calcium, more risk.

Beyond the raw number, reporting guidelines recommend including your age-, sex-, and race-specific percentile, how many of the four main coronary vessels contain calcium, and whether calcium appears in the left main artery, which supplies a large portion of the heart muscle.² A score of 150 in a 75-year-old woman may fall near the median for her demographic group, while the same score in a 45-year-old man could land well above the 90th percentile. Context matters more than the number alone.

The Power of Zero and Its Limits

A calcium score of zero is genuinely reassuring. Pooled data from studies tracking over 35,000 asymptomatic people found that those with a zero score had an annual cardiovascular event rate of about 0.03%, and the negative predictive value of a zero score was essentially 100%.³ That finding has been called the “power of zero” because it can effectively de-risk people who might otherwise be started on medications like statins based on traditional risk calculators alone.⁴

But zero does not mean zero plaque. The scan detects only calcified deposits; soft, fatty plaque that has not yet calcified is invisible to it. Studies of patients with symptoms who had a zero calcium score but then underwent full contrast-enhanced CT angiography found that roughly a quarter to a third still had some degree of coronary artery disease from non-calcified plaque, and a small percentage had obstructive lesions.^{5 6} This is especially relevant in younger patients and certain ethnic groups where soft plaque may be more common relative to calcified plaque. In an asymptomatic person with no other red flags, a zero score is strong grounds for confidence. In someone with chest pain or significant symptoms, a zero score alone should not end the conversation.

Who Should Consider Getting Tested

Major cardiology guidelines from both North America and Europe have converged on a fairly consistent recommendation: CAC scoring is most useful for people in the borderline or intermediate risk zone, roughly a 5% to 20% estimated ten-year risk of a cardiovascular event, where the decision about whether to start statin therapy is genuinely uncertain.⁷ Expert consensus also supports testing people in the lower-risk group who have a family history of premature heart disease, since traditional risk calculators may underestimate their actual risk.⁸

The scan is generally recommended for adults between 40 and 75 years of age. Below 40, calcium scores are almost universally zero, so the test tells you little. Above 75, most people have at least some calcium, and statin therapy is often already indicated regardless of the score. In either case, the test rarely changes management. The sweet spot is that middle-aged group where a score can genuinely tip the scales.

How a Score Changes Treatment Decisions

The practical value of a calcium score lies in what happens next. A systematic review and meta-analysis found that adding the calcium score to traditional risk models correctly reclassified a meaningful number of people: among those initially categorized as intermediate or high risk by standard equations, roughly 19% to 29% were correctly moved to low risk when their calcium score turned out to be zero, sparing them unnecessary medication.⁹ Reclassification in the other direction, moving low-risk people up after finding unexpected calcium, was less common but still clinically important.

For statin decisions specifically, a cost-effectiveness analysis found that measuring calcium and then targeting statin therapy to those with any detectable calcium captured about 45% of the overall benefit of treating everyone, while treating far fewer people.¹⁰ Whether that selective approach beats simply treating everyone depends on the cost and side-effect burden of statins, which varies from person to person.

The score also influences aspirin decisions. Data from the Multi-Ethnic Study of Atherosclerosis showed that people with a calcium score of 100 or above had favorable risk-to-benefit ratios for daily aspirin, with a five-year number needed to treat of about 92 to 173, well outweighing the bleeding risk. People with a zero score, by contrast, were estimated to experience net harm from aspirin regardless of their traditional risk level, because the chance of a bleeding event outweighed the small chance of preventing a heart attack.¹¹ A more recent systematic review reinforced the pattern: in patients without elevated bleeding risk and a score of 100 or above, aspirin showed clear net benefit.¹²

Scores Change Over Time

Coronary calcium is not static. The underlying process begins as microscopic mineral deposits smaller than a red blood cell and gradually grows into larger fragments and eventually sheet-like deposits several millimeters across, all in tandem with the growth of atherosclerotic plaque itself.¹³ The biology driving this involves cells in the artery wall that begin behaving like bone-forming cells, laying down mineral in the vessel wall in much the same way bones are built.¹⁴

In a study of asymptomatic people followed for an average of three and a half years, about 13% of those who started with a zero score developed new calcium, and over half of those who already had calcium at baseline showed rapid progression.¹⁵ Newly diagnosed high blood pressure was the strongest independent predictor of rapid calcium progression in that study. This is why a zero score at age 50 does not guarantee a zero score at 55, especially if risk factors go uncontrolled in the interim.

The Statin-Calcification Paradox

If you have been prescribed a statin and then get a repeat calcium scan, the number may actually go up. This confuses a lot of people, since statins are supposed to fight heart disease. Research using intravascular imaging has shown that statins promote calcification of existing plaques even as they shrink the overall plaque volume and stabilize its structure.¹⁶ Think of it like a soft, crumbly wall being reinforced with concrete: the wall gets denser and harder but is less likely to crumble and cause a blockage.

A separate analysis found that the longer someone had been on statin therapy, the higher their calcium score tended to be, with each additional year of use associated with a meaningful increase.¹⁷ This does not mean statins are making things worse. It means the calcium score, once someone is on a statin, no longer means what it would in an untreated person. Doctors interpreting a follow-up scan need to factor in statin use, and patients should not panic over a rising number if they are already on treatment.

Scores Vary by Age, Sex, and Ethnicity

The Multi-Ethnic Study of Atherosclerosis, a large U.S. study, documented significant differences in calcium scores across demographic groups. Men had consistently more calcium than women, and scores rose steadily with age in both sexes. There were also clear differences by race and ethnicity, with some groups showing higher average calcium burdens at any given age than others.¹⁸ This is why percentile rankings adjusted for these factors are an essential part of the report. A raw Agatston score without demographic context can be misleading in both directions.

These differences also mean that a single set of score thresholds does not fit everyone equally well. A woman with a score of 50 at age 55 may be at a higher relative risk for her demographic group than a man with the same score at the same age. Tools like the free online MESA calculator allow clinicians to convert a raw score into a percentile and a ten-year risk estimate that accounts for these variables along with traditional risk factors.²

Radiation Exposure

The radiation dose from a standard calcium scoring scan is low. In the Multi-Ethnic Study of Atherosclerosis, the average effective dose was about 1 millisievert (mSv), with a median just under 1 mSv.¹⁹ An earlier survey of CT protocols across multiple centers found a wider range, from about 0.8 to over 10 mSv depending on the equipment and technique used, with a median of roughly 2.3 mSv.²⁰ Modern scanners at experienced centers tend to land at the lower end of that range. For comparison, the background radiation you absorb from natural sources over the course of a year is about 3 mSv, so a single calcium scan adds a fraction of that.

What Else the Scan Can Show

Because the scan images a cross-section of your chest, radiologists sometimes spot findings unrelated to your coronary arteries. Lung nodules are the most common incidental discovery, followed by liver cysts and other benign findings.²¹ In one study, about 43% of participants had some kind of incidental finding, though only 17% had anything considered clinically significant, and most turned out to be stable on follow-up.²² Older patients and current smokers are more likely to have incidental findings, particularly pulmonary nodules. For smokers, in particular, an unexpected lung nodule can trigger further evaluation under established guidelines for lung cancer screening, which is a secondary benefit of the scan worth knowing about.

When a Calcium Score Is Not Enough

The calcium score measures plaque burden but does not show whether any artery is actually narrowed enough to restrict blood flow. For that, you need coronary CT angiography (CCTA), which uses contrast dye to visualize the inside of the arteries and grade stenosis directly. Studies have found that adding CCTA to a calcium score significantly improves the ability to predict future cardiac events. In one analysis, the predictive accuracy jumped from 0.71 for clinical risk factors alone, to 0.82 with the addition of the calcium score, and to 0.93 when CCTA was added on top.¹ CCTA also revealed that not all plaques are equal: noncalcified and mixed plaques carried higher event rates than purely calcified ones, a distinction the calcium score alone cannot make.²³

For asymptomatic people at borderline risk, the calcium score is often enough to guide prevention decisions. But for someone with symptoms like chest pain or shortness of breath, especially if the calcium score is low or zero, a contrast-enhanced study may be the smarter next step to rule out soft plaque or other causes.

AI and Opportunistic Scoring from Routine Chest CTs

One of the more promising developments is the ability to extract calcium scores from CT scans that were done for entirely different reasons. Every year, millions of chest CTs are performed for things like lung cancer screening, trauma, or pneumonia workup. Those scans capture the heart whether anyone asked them to or not. Artificial intelligence algorithms are now being trained to read those images and generate a calcium score automatically, without the need for a separate ECG-gated scan.²⁴

Validation studies show strong correlation between AI-generated scores from non-gated chest CTs and scores from dedicated cardiac scans, particularly when thinner image slices are used.²⁵ The AI approach also dramatically reduces the time a radiologist would need to measure calcium manually.²⁶ If widely adopted, this could turn every routine chest CT into an opportunistic cardiovascular screen, flagging people with unsuspected calcium who might otherwise never get a dedicated cardiac scan.

Insurance and Out-of-Pocket Cost

Despite guideline endorsements, insurance coverage for coronary calcium scoring remains frustratingly inconsistent in the United States. Most private payers do not cover the test for asymptomatic screening, even in intermediate-risk patients for whom guidelines specifically recommend it.²⁷ Cardiology organizations have called for insurers to cover selective calcium testing for primary prevention.²⁸ Out-of-pocket costs typically range from about $75 to $300, depending on your location and the imaging center, making it one of the more affordable cardiac tests. Cost-effectiveness analyses have generally found the scan reasonable in men at intermediate risk, though the picture is less clear for women, where following existing treatment guidelines without imaging may produce comparable outcomes at similar cost.²⁹

Psychological Impact of Getting Your Score

Receiving a number that quantifies your heart disease risk can feel different from being told your cholesterol is a bit high. In the ROBINSCA trial, which randomized participants to either CT-based screening or traditional risk-factor assessment, overall quality of life and anxiety levels were comparable between the two approaches at most time points. However, there was a clear bump in anxiety among the CT group after receiving results that indicated heightened risk.³⁰ That spike tended to be temporary, and both groups saw anxiety decrease over the longer follow-up period. Still, if you are the kind of person who spirals over health numbers, it is worth knowing that a high score can hit hard emotionally, even when the clinical next step is straightforward. Having the conversation with your doctor before and after the scan, rather than just looking at a number on a patient portal, makes a real difference.